[ASSISTANT] {"action": "list_documents"}
[OBSERVATION] DOCUMENTS
asset-valuation-summary.xlsx
beacon-operating-agreement.docx
prism-cap-table.xlsx
purchase-agreement-excerpts.docx
shareholder-qsbs-email-thread.eml
tax-due-diligence-report.docx
transaction-structure-memo.docx
[ASSISTANT] {"action": "read_document", "name": "transaction-structure-memo.docx"}
[READ] transaction-structure-memo.docx
[OBSERVATION] **CALLOWAY, STERN & WHITAKER LLP** *Attorneys at Law*

301 South Tryon Street, Suite 4200 Charlotte, North Carolina 28202
Telephone: (704) 555-3800 \| Facsimile: (704) 555-3801

**PRIVILEGED AND CONFIDENTIAL --- ATTORNEY-CLIENT COMMUNICATION /
ATTORNEY WORK PRODUCT** This memorandum is protected by the
attorney-client privilege and the work product doctrine. It is intended
solely for the use of th
[ASSISTANT] {"action": "read_document", "name": "tax-due-diligence-report.docx"}
[READ] tax-due-diligence-report.docx
[OBSERVATION] **THORNFIELD ACCOUNTING GROUP, LLP** 191 Peachtree Street NE, Suite 2800
Atlanta, GA 30303

**TAX DUE DILIGENCE REPORT**

**PRISM HEALTH ANALYTICS, INC.**

Prepared for **Ridgeline Capital Partners, LP** and **Calloway, Stern &
Whitaker LLP**

Project Prism --- Tax Due Diligence Engagement Reference: TAG-2024-0917

January 15, 2025

**CONFIDENTIAL --- DRAFT**

This report is confidential and has b
[ASSISTANT] {"action": "read_document", "name": "purchase-agreement-excerpts.docx"}
[READ] purchase-agreement-excerpts.docx
[OBSERVATION] **[AGREEMENT AND PLAN OF MERGER]{.underline}**

by and among

**RIDGELINE CAPITAL PARTNERS FUND III, LP,**

**RIDGELINE ACQUISITION SUB, INC.,**

**PRISM HEALTH ANALYTICS, INC.,**

and

**THE SHAREHOLDERS OF PRISM HEALTH ANALYTICS, INC.** *(solely with
respect to certain provisions herein)*

Dated as of January 28, 2025

\[Note: The following are selected excerpts from the Agreement and Plan
of Me
[ASSISTANT] {"action": "read_document", "name": "beacon-operating-agreement.docx"}
[READ] beacon-operating-agreement.docx
[OBSERVATION] CONFIDENTIAL --- PROVIDED IN CONNECTION WITH DUE DILIGENCE FOR PROPOSED
ACQUISITION OF PRISM HEALTH ANALYTICS, INC.

**AMENDED AND RESTATED OPERATING AGREEMENT**

**OF**

**BEACON INSIGHTS, LLC**

**A North Carolina Limited Liability Company**

*Selected Provisions --- Excerpted for Transaction Review Purposes*

Effective Date: August 1, 2018

Originally formed by filing of Articles of Organizatio
[ASSISTANT] {"action": "read_document", "name": "shareholder-qsbs-email-thread.eml"}
[READ] shareholder-qsbs-email-thread.eml
[OBSERVATION] (conversion failed: Command '['/Users/xiongweixiao/main/OpenSource/nanoRSI/.omx/harness2/dependencies/harvey-labs/.venv/bin/python', '-c', '\nimport sys\nfrom pathlib import Path\nname, path = sys.argv[1], Path(sys.argv[2])\nout = []\nif name.endswith(".xlsx"):\n    import openpyxl\n    book = openpyxl.load_workbook(path, data_only=True)\n    for sheet in book.worksheets:\n        out.append(f"## 
[ASSISTANT] {"action": "read_document", "name": "shareholder-qsbs-email-thread.eml"}
[READ] shareholder-qsbs-email-thread.eml
[OBSERVATION] (conversion failed: Command '['/Users/xiongweixiao/main/OpenSource/nanoRSI/.omx/harness2/dependencies/harvey-labs/.venv/bin/python', '-c', '\nimport sys\nfrom pathlib import Path\nname, path = sys.argv[1], Path(sys.argv[2])\nout = []\nif name.endswith(".xlsx"):\n    import openpyxl\n    book = openpyxl.load_workbook(path, data_only=True)\n    for sheet in book.worksheets:\n        out.append(f"## 
[ASSISTANT] {"action": "read_document", "name": "prism-cap-table.xlsx"}
[READ] prism-cap-table.xlsx
[OBSERVATION] ## sheet: Cap Table
Shareholder Name | Shareholder Type | Share Class | Shares Outstanding | % Ownership (Basic) | Restricted Stock Shares | Total Shares (Fully Diluted) | % Ownership (Fully Diluted) | S Corp Eligible Shareholder? | Notes
Dr. Naveen Chandra | Individual | Common | 1,014,000 | 52.00% | 0 | 1,014,000 | 50.83% | Yes | Co-Founder & CEO; NC resident
Rachel Stowe | Individual | Common |
[ASSISTANT] {"action": "read_document", "name": "asset-valuation-summary.xlsx"}
[READ] asset-valuation-summary.xlsx
[OBSERVATION] ## sheet: Asset Detail
Asset ID | Asset Description | Legal Entity Owner | IRC Section 1060 Class | Class Description | Adjusted Tax Basis (Book) | Preliminary Fair Market Value | Valuation Methodology | Useful Life (Years) | Amortizable / Depreciable (Y/N) | IRC Section | Notes / Assumptions
A-001 | Cash and cash equivalents (operating accounts) | Prism Health Analytics, Inc. | I | Cash & Cash Eq
[ASSISTANT] {"action": "write_deliverable", "filename": "tax-issue-identification-report.docx"}
[WRITE] tax-issue-identification-report.docx (20689 chars)
[OBSERVATION] wrote tax-issue-identification-report.docx
[ASSISTANT] {"action": "done", "summary": "Delivered tax-issue-identification-report.docx, a severity-ranked review flagging the memo's $48M ADSP double-count, unverified S corp shareholder eligibility, omitted Beacon Class V interest/ROFR, QSBS and rollover omissions, R&D credit and §482 exposures, and other i